GST reforms, RDI scheme strengthened Indian pharma in 2025, innovation & access key for 2026 - The Hans India
GST reforms, RDI scheme strengthened Indian pharma in 2025, innovation & access key for 2026 The Hans India
Why this GST update matters
This article highlights a GST-related development that may be relevant for understanding regulatory trends, compliance focus areas, or policy interpretation. Tracking such updates helps readers stay informed about how GST rules and enforcement practices continue to evolve.